
Broad-Based Technical Strength Lifts Nexus Surgical and Medicare Ltd to 52-Week High of Rs 27.4
2026-09-03 09:40:33With a surge to Rs 27.4 on 3 Sep 2026, Nexus Surgical and Medicare Ltd has reached a fresh 52-week high, marking a 48.65% gain over the past year and significantly outperforming the Sensex, which has declined 4.63% in the same period.
Read full news article
Nexus Surgical and Medicare Ltd Downgraded to Sell Amid Mixed Technicals and Valuation Concerns
2026-07-14 08:08:38Nexus Surgical and Medicare Ltd, a micro-cap player in the Non Banking Financial Company (NBFC) sector, has seen its investment rating downgraded from Hold to Sell as of 13 July 2026. This change reflects a complex interplay of technical indicators, valuation metrics, financial trends, and quality assessments, signalling caution for investors despite the company’s strong long-term fundamentals and recent positive quarterly results.
Read full news article
Nexus Surgical and Medicare Ltd Upgraded to Hold on Improved Technicals and Financial Trends
2026-07-09 08:05:15Nexus Surgical and Medicare Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a marked improvement in technical indicators and sustained financial performance. The company’s micro-cap status in the Non Banking Financial Company (NBFC) sector, combined with strong returns and positive quarterly results, has prompted analysts to revise their outlook, signalling cautious optimism for investors.
Read full news article
Nexus Surgical and Medicare Ltd Downgraded to Sell Amid Mixed Technicals and Valuation Concerns
2026-07-07 08:11:12Nexus Surgical and Medicare Ltd, a micro-cap player in the Non Banking Financial Company (NBFC) sector, has seen its investment rating downgraded from Hold to Sell as of 6 July 2026. This shift reflects a nuanced reassessment across four key parameters: quality, valuation, financial trend, and technicals. Despite strong long-term fundamentals and positive recent financial results, concerns over valuation and mixed technical signals have prompted a more cautious stance.
Read full news article
Nexus Surgical and Medicare Ltd Upgraded to Hold on Technical and Financial Improvements
2026-06-30 08:08:27Nexus Surgical and Medicare Ltd, a micro-cap player in the Non Banking Financial Company (NBFC) sector, has seen its investment rating upgraded from Sell to Hold as of 29 June 2026. This change reflects improvements across technical indicators, financial trends, valuation metrics, and overall quality, signalling a more favourable outlook for investors despite some valuation concerns.
Read full news article
Nexus Surgical and Medicare Ltd Downgraded to Sell Amid Mixed Technicals and Valuation Concerns
2026-06-24 08:05:53Nexus Surgical and Medicare Ltd, a micro-cap player in the Non Banking Financial Company (NBFC) sector, has seen its investment rating downgraded from Hold to Sell as of 23 June 2026. The downgrade follows a detailed reassessment of the company’s quality, valuation, financial trend, and technical indicators, reflecting a nuanced picture of strong fundamentals tempered by valuation pressures and mixed technical signals.
Read full news article
Nexus Surgical and Medicare Ltd Upgraded to Hold on Technical and Financial Improvements
2026-06-16 08:06:49Nexus Surgical and Medicare Ltd, a micro-cap player in the Non Banking Financial Company (NBFC) sector, has seen its investment rating upgraded from Sell to Hold as of 15 June 2026. This change reflects improvements across technical indicators, financial performance, valuation metrics, and overall quality, signalling a more balanced outlook for investors amid mixed market conditions.
Read full news article
Nexus Surgical and Medicare Ltd Downgraded to Sell Amid Mixed Technical and Valuation Signals
2026-06-08 08:04:14Nexus Surgical and Medicare Ltd, a micro-cap player in the Non Banking Financial Company (NBFC) sector, has seen its investment rating downgraded from Hold to Sell as of 5 June 2026. This shift reflects a nuanced reassessment across four key parameters: quality, valuation, financial trend, and technicals. Despite strong long-term fundamentals and positive quarterly results, the downgrade is primarily driven by deteriorating technical indicators and expensive valuation metrics.
Read full news articleBoard Meeting Intimation for Notice Of Board Meeting Scheduled To Be Held On Wednesday 2Nd September 2026
25-Aug-2026 | Source : BSENexus Surgical And Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/09/2026 inter alia to consider and approve 1. approve the Directors Report alongwith annexures on the Audited Financial Statements of the Company for the financial year ended on 31st March 2026;
Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday 13Th August 2026
13-Aug-2026 | Source : BSEOutcome of Board Meeting of the Company held on Thursday 13th August 2026
Results - Financial Results For 30Th June 2026
13-Aug-2026 | Source : BSESubmission of Unaudited Quarterly Financial Results of the Company for the quarter ended 30th June 2026
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






